Noteworthy, in TCGA as well as in HD, significant results were in particular reached in subcohorts composed of younger patients, patients with high KPI, and patients treated with standard therapy scheme (PORT, TMZ), whereas miR expression had no prognostic influence in IDH1-mutated GBM (TCGA). The gene discussed is IDH1; the disease is glioblastoma.